Literature DB >> 6315747

Erythropoietin causes down regulation of colony-stimulating factor (CSF-1) receptors on peritoneal exudate macrophages of the mouse.

G Van Zant, B D Chen.   

Abstract

We have shown that erythropoietin (epo), the primary regulator of erythrocyte formation, diminished the binding to peritoneal exudate macrophages (PEM) of the principal macrophage growth regulator, colony-stimulating factor (CSF-1). The effect of epo on 125I-CSF-1 binding was dose-dependent; at a concentration of 1-2 U of epo/ml (10(-10) M), CSF-1 binding was almost completely suppressed. Erythropoietin did not compete with CSF-1 for occupancy of the latter's receptors. The effect of epo on CSF-1 binding occurred at 37 degrees C but not at 2 degrees C, and during the continuous exposure of PEM to epo at 37 degrees C we found that CSF-1 binding reached a nadir at 1 h and recovered to pre-exposure levels in 7 h. Our novel results are consistent with the notion that specific receptors for epo exist on the cell surface of PEM and that binding of epo sets in motion a series of cellular events resulting in the internalization of CSF-1 receptors. Thus epo causes down regulation of CSF-1 receptors on PEM. We have previously shown that epo causes suppression of CSF-induced granulocyte-macrophage colony formation by mouse bone marrow cells. The results we present here provide a possible mechanism for these results.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315747      PMCID: PMC2112742          DOI: 10.1083/jcb.97.6.1945

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  25 in total

1.  Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells.

Authors:  J Schlessinger; Y Shechter; M C Willingham; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Factors regulating macrophage production and growth. Purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells.

Authors:  E R Stanley; P M Heard
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

3.  Induction of macrophage production and proliferation by a purified colony stimulating factor.

Authors:  E R Stanley; D M Chen; H S Lin
Journal:  Nature       Date:  1978-07-13       Impact factor: 49.962

4.  Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells.

Authors:  A Aharonov; R M Pruss; H R Herschman
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

5.  Simultaneous effects of erythropoietin and colony-stimulating factor on bone marrow cells.

Authors:  G Van Zant; E Goldwasser
Journal:  Science       Date:  1977-11-18       Impact factor: 47.728

6.  Erythropoietin and the differentiation of red blood cells.

Authors:  E Goldwasser
Journal:  Fed Proc       Date:  1975-12

7.  Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.

Authors:  P Ralph; J Prichard; M Cohn
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

8.  Purification of human erythropoietin.

Authors:  T Miyake; C K Kung; E Goldwasser
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

9.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

10.  Tumor-promoting phorbol esters inhibit the binding of colony-stimulating factor (CSF-1) to murine peritoneal exudate macrophages.

Authors:  B D Chen; H S Lin; S Hsu
Journal:  J Cell Physiol       Date:  1983-08       Impact factor: 6.384

View more
  1 in total

1.  Specific binding of radioiodinated granulocyte-macrophage colony-stimulating factor to hemopoietic cells.

Authors:  F Walker; A W Burgess
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.